ABSTRACT The airway response to the inhalation of ultrasonically nebulised distilled water was determined in 55 asthmatic patients and 16 normal subjects. We calculated the dose of water required to induce a 20% reduction (PD20) in forced expiratory volume in one second (FEVy) by measuring the output of the nebuliser and the volume ventilated by each subject. Forty-eight of the asthmatic patients had a PD20 of 9 ml or less but three patients required as much as 24 ml. A PD20 was not recorded in the normal subjects and the challenge was stopped after 33 ml. In 12 patients the challenge was repeated within six months and the airway response was shown to be reproducible at equivalent doses of water. In a separate group of 11 patients there was, however, a highly significant reduction in the percentage fall in FEV, when equivalent doses of water were given on two occasions 40 minutes apart. When the temperature of the inhaled water was increased from 22°C to 36°C eight of 10 patients had a similar change in FEV, with equivalent doses of water. The airways obstruction induced by the inhalation of water was readily reversed with salbutamol administered by aerosol. In some patients a challenge with water or 3.6% saline was repeated after pretreatment with sodium cromoglycate, atropine methonitrate, and verapamil hydrochloride, all given as aerosols. The airway response to the equivalent dose of water or saline was significantly reduced after treatment with sodium cromoglycate but not atropine or verapamil.
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The measurement of the airway response to the inhalation of ultrasonically nebulised solutions of hypotonic and hypertonic solutions provides a new approach for the investigation of nonimmunologically mediated bronchial reactivity.
We have previously measured airway reactivity to these solutions by determining the total volume of inhaled aerosol (that is, ventilation) required to reduce the forced expiratory volume in one second (FEVy) by 20% of the pre-challenge value. ' Other workers have measured changes in airway resistance after administering the inhaled solutions for a specified time, usually five minutes.2 There are many different ultrasonic nebulisers in use and the output of aerosol is likely to vary between nebulisers. The measurement of the volume of inhaled aerosol or the time of aerosol delivery alone does not permit a comparison to be made between asthmatic patients studied in different laboratories.
For this reason we have determined the delivered dose required to induce a 20% reduction in FEV1 and compared the responses in FEV, to equivalent doses of water under different conditions. Furthermore, we have measured the proportion of a delivered dose which is retained by the patient. We have also studied the effects of sodium cromoglycate, atropine methonitrate, and verapamil hydrochloride on the airway response to the same dose of inhaled solution.
Methods
We studied 55 patients aged 11-56 years (mean ± SD 28-5 + 10-8 years) with clinically recognised asthma who were taking beta-sympathomimetic aerosols regularly for control of their symptoms. All medications were withheld for at least four hours before any test. The protocol was approved by the ethics review committee and informed consent obtained. Sixteen non-asthmatic subjects volunteered as controls. The The effect of sodium cromoglycate (20 mg) and (separately) of atropine methonitrate (0-1-1.0% for 10 minutes) was investigated in nine patients who were challenged with both distilled water and 3-6% saline. A separate group of nine patients were challenged with distilled water after the administration of verapamil hydrochloride (12.5 mg). All medications were delivered as aerosols (10-15 minutes before challenge) through a Hudson mask and Acorn nebuliser which was attached to a cylinder of compressed air giving a driving pressure of 10 lb/in2 (69 kPa). The Acorn nebuliser delivered particles in the range of 2-10 l m. In the verapamil study isotonic saline (5 ml) was administered by the Acorn nebuliser as a placebo control 10-15 minutes before challenge with distilled water.
A dose-response curve was drawn for each patient relating the fall in FEV, (expressed as a percentage of the pre-challenge value) after each challenge (that is, 101, 201, 401, etc) to the cumulative dose of aerosol water required to induce that fall in FEVI.
The dose of aerosol water was determined from the ventilation required to induce the fall in FEV by using the appropriate equation for the output ol the nebuliser (see below). Bronchial reactivity to the aerosols was assessed in several ways. Firstly, the dose (in ml) of the aerosol water required to induce a fall in FEVI of 20% of the pre-challenge level was determined from the dose-response curve for each patient. In this way the sensitivity to inhaled water could be compared within the patient population. Secondly, the response in FEVy was compared after the same dose of an aerosol (either distilled water or 3-6% saline) had been given on separate occasions to the same patient.
An index of protection was used to assess the effect of a drug and was calculated as the difference between the fall in FEV, induced by challenge after pretreatment and the fall induced by challenge without pretreatment, expressed as a percentage of the fall induced by challenge without pretreatment. A value for protection greater than 60% has been taken as a significant drug effect.
Normal predicted values for FEV1 were taken from the data of Goldman and Becklake.3
Regression coefficients were determined by the standard methods described by Snedecor and Cochran. 4 The coefficient of variation for repeated measurements in the same subjects was determined by the standard deviation of the differences between the tests expressed as a percentage of the overall mean. A t test was used to determine the significance of differences between paired values in the same subject. A p value less than 0*05 was taken as statistically significant.
Results
The output of the ultrasonic nebuliser was constant and linearly related to the total volume taken through the silica gel for each test. The output was unaffected by temperature, flow rate, or frequency of respiration simulated by the motor blower; but the length of tubing between the nebuliser and motor blower had a small effect. The regression equations for the output and volume for both lengths of tubing used are given in table 1 (equations 1 and 2).
There was a small reduction in FEV1 from the resting value in response to breathing 40 1 of room air-mean (SD) 4*96% (7.9) in the asthmatics and 1-2% (1.8) in the normal subjects. All a fall in FEV1 of 20% after the inhalation of distilled water and 3.6% saline. No normal subject had a fall in FEV, of 20% or more of the initial value and the challenge was terminated after 33 ml water or 3.6% saline had been given. The delivered doses of water required to induce a 20% fall in FEVI (PD20) in the 55 patients are shown in figure 1. There was a wide variation in the dose of water required to induce the same fall in FEVI. Twenty-eight (51 %) of the patients had a PD20 of 2 ml or less and 48 (87%) had a PD20 less than 10 ml. Seven patients however, Table 1 Regression equations for (I and 2) the output of the nebuliser (ml) in relation to the volume (litres) of aeroso delivered; (3 and 4) the resting level offorced expiratory volume in one second (FEV,) expressed as percentage ofpredicted volume (RlP%) in relation to the dose (ml) of water required to induce a 20% fall in FEV, (PD2d; (S) the FEV, R/P% in relation to that part ofthe delivered dose which was retained (DR); (6) V. w group.bmj.com on June 25, 2017 -Published by http://thorax.bmj.com/ Downloaded from ultrasonically nebulised water was observed within four minutes, so the test is very rapid for use as a routine provocation test. The least responsive patients, however, took 20-25 minutes to be tested.
Many patients were highly reactive to the effects of inhaled water at a time when their FEV, was within normal limits. It was not possible, however, to predict sensitivity to the inhaled water from the resting level of FEV in the 48 patients who had a PD20 less than 10 mf. In 16 non-asthmatic subjects there was no PD20 recorded after the inhalation of 33 ml water or 3X6% saline. In the asthmatic patients the highest dose delivered to elicit a positive response was 23-8 ml. Since normal subjects had no response after 33 ml they would seem to be well separated from the asthmatic population.
Because there was relatively little variation in the proportion of water retained (despite enormous differences in the resting level of airways obstruction) we have not corrected the values for the delivered dose of water or saline. Although the amount of water retained was similar in the patients and normal subjects we do not know the site of deposition of the aerosol, which may have been different in the patients with airways obstruction before challenge.
It has been suggested that bronchial reactivity is enhanced in the presence of bronchoconstriction.5
We did not observe an increased reactivity to water in relation to resting lung function either in the group of 55 patients or in a patient who performed the same challenge on several occasions. In fact, we observed an appreciable reduction in airway response to the same dose of water given 40 minutes later at a time when airways obstruction was still present after the initial challenge. Some bronchial reactivity was, however, still present in seven of the 10 patients. The increased tolerance of water inhalation may be due to availability of fewer "osmosensitive" receptor sites or to failure of the water to reach the site as a result of a change in membrane permeability. Perhaps changes in osmolarity within the respiratory tract induce a "down regulation" of receptors resulting in desensitisation and subsequent tolerance. Further studies are required to elucidate the decreased responsiveness observed with a challenge repeated within an hour.
The mechanism by which a reduction in FEV, occurs in patients with asthma in response to the inhalation of water and 3.6% saline is unknown.The considerable increase in FEV, after the administration of nebulised salbutamol implies that the reduction in FEV, which occurred after the inhalation of these aerosols was due to contraction of airway smooth muscle. The mechanism by which bronchoconstriction occurs presumably relates to the osmolarity of the aerosol. Isotonic saline has little, if any, effect on FEV, when delivered by ultrasonic nebuliser' and it had no effect in a dose of 5 ml delivered by an Acorn nebuliser in this study. Distilled water and 3-6% saline appear to be equally potent in causing bronchoconstriction and similar responses in FEV, have been observed in our laboratory for asthmatic patients challenged with 20% dextrose.' A significant bronchoconstrictor stimulus is unlikely to be explained by the fact that the aerosol was inhaled at room temperature since in eight patients the response was reproducible when the temperature of the aerosol was increased to 360C.
The observation that sodium cromoglycate was effective in inhibiting the response in all patients suggests several possibilities. Mediators from mast cells in the bronchial mucosa may be released in response to hypotonic and hypertonic solutions. Mast cells in vitro are known to release histamine in hypotonic solutions and basophils have been reported to release histamine in hypertonic solutions.67 Possibly sodium cromoglycate protects the cell against conformational changes in response to change in the osmotic pressure of the surrounding fluid.8 Transient changes in the environment of mast cells or irritant receptors may be all that is required to induce mediator release and smooth muscle contraction, either directly or via the vagus nerve. It is now thought that sodium cromoglycate may reduce reflex bronchoconstriction by an action on the postganglionic arm of the vagal reflex, but this has been shown only in dogs.9
A protective effect was noted in some patients after pretreatment with atropine, which suggests that reflex bronchoconstriction may have been occurring in these patients at least. Others, however, had an increased response after atropine, which makes the results difficult to interpret. Although a 1 % solution was used, most patients complained of a severe dry mouth and throat and for this reason the dose was reduced to 0.1 % for two patients (Nos 34 and 37). Patient 36 was as well protected by 0-1% on challenge with water as by 1-0% on challenge with 3-6% saline. The period of 10-15 minutes between administration and challenge was insufficient to observe the usual bronchodilating effect of atropine,'0 but it is long enough for atropine to prevent induced asthma." Allegra and Bianco2 made similar observations in studying the effect of sodium cromoglycate but failed to show any inhibition of the airway response to distilled water after pretreatment with the anticholinergic ipratropium bromide.
Since The Acorn nebuliser delivers particles with a mass median diameter similar to that of particles delivered by the ultrasonic nebuliser. The drugs would therefore presumably be delivered to the same site in the lung as the ultrasonic mist, although the density of the particles may not have been the same. In the study of Allegra and Bianco2 the failure of ipratropium bromide may have been due to the method of delivery.
In patients in whom two inhalational challenges were carried out 
